NFE2L2 and laryngeal carcinoma: Variant genotypes rs1303586 GA+AA and rs2706110 CT+TT, both in the NRF2 gene, were associated with a lower risk of laryngeal carcinoma (p = 0.035, OR = 0.478 (0.240–0.949) and p = 0.518, OR = 0.518 (0.299–0.900), respectively) (Table 2 and Table S2).